Company
Every investor coverage indicates participated in a round U.S. Renal Care raised.
Companies U.S. Renal Care acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming U.S. Renal Care. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Ten13's post explains why it joined the robotics company's latest raise alongside Blackbird, Neotribe, Startmate and Horizons, covering its autonomous scanning device, dialysis focus, founders, and US rollout plans.
Australian medical robotics firm Vexev has raised A$8.6 million to pursue FDA clearance and US commercialisation of its VxWave robotic ultrasound platform, with backing from existing and new investors.
Also Startup Daily·This Week in Australian Startups·SmartCompany